Humoral Pattern Recognition and the Complement System

Scandinavian Journal of Immunology

Volumn 78, Issue 2, 2013, Pages 181-193

  Degn, S E ^a   Thiel, S ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; ACETYLCHOLINE; ACETYLCYSTEINE; ALANINE; C REACTIVE PROTEIN; CARBOHYDRATE; CHEMICALCOMPOSITION; COLLAGEN; COLLECTIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; COMPLEMENT FACTOR H; DIMER; FICOLIN; GLYCINE; HOMODIMER; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LECTIN; MANNOSE BINDING LECTIN; MEMBRANE PROTEIN; OLIGOMER; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN CLP 1; SIALIC ACID DERIVATIVE; TETRAMER; UNCLASSIFIED DRUG;

BINDING SITE; CHEMICAL COMPOSITION; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONFORMATIONAL TRANSITION; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXON; GEL PERMEATION CHROMATOGRAPHY; INNATE IMMUNITY; LIGAND BINDING; NONHUMAN; OLIGOMERIZATION; PATTERN RECOGNITION; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; ULTRASTRUCTURE;

ANTIGEN-ANTIBODY COMPLEX; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; COMPLEMENT SYSTEM PROTEINS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, HUMORAL; IMMUNITY, INNATE; MODELS, IMMUNOLOGICAL; PROTEIN MULTIMERIZATION; PROTEOLYSIS; RECEPTORS, PATTERN RECOGNITION;

EID: 84880682970     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12070     Document Type: Review

References (102)

1. Janeway CA Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989;54(Pt 1):1-13.
2. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045.
3. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
4. Blander JM, Sander LE. Beyond pattern recognition: five immune checkpoints for scaling the microbial threat. Nat Rev Immunol 2012;12:215-25.
5. Gaboriaud C, Juanhuix J, Gruez A et al. The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J Biol Chem 2003;278:46974-82.
6. Kishore U, Reid KB. C1q: structure, function, and receptors. Immunopharmacology 2000;49:159-70.
7. Kilchherr E, Hofmann H, Steigemann W, Engel J. Structural model of the collagen-like region of C1q comprising the kink region and the fibre-like packing of the six triple helices. J Mol Biol 1985;186:403-15.
8. Kishore U, Gaboriaud C, Waters P et al. C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol 2004;25:551-61.
9. Cooper NR. The classical complement pathway: activation and regulation of the first complement component. Adv Immunol 1985;37:151-216.
10. Czajkowsky DM, Shao Z. The human IgM pentamer is a mushroom-shaped molecule with a flexural bias. Proc Natl Acad Sci U S A 2009;106:14960-5.
11. Szalai AJ, Agrawal A, Greenhough TJ, Volanakis JE. C-reactive protein: structural biology and host defense function. Clin Chem Lab Med 1999;37:265-70.
12. Budayova-Spano M, Lacroix M, Thielens NM, Arlaud GJ, Fontecilla-Camps JC, Gaboriaud C. The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex. EMBO J 2002;21:231-9.
13. Dodds AW, Ren XD, Willis AC, Law SK. The reaction mechanism of the internal thioester in the human complement component C4. Nature 1996;379:177-9.
14. Law SK, Dodds AW. The internal thioester and the covalent binding properties of the complement proteins C3 and C4. Protein Sci 1997;6:263-74.
15. Dodds AW, Matsushita M. The phylogeny of the complement system and the origins of the classical pathway. Immunobiology 2007;212:233-43.
16. Matsushita M, Matsushita A, Endo Y et al. Origin of the classical complement pathway: lamprey orthologue of mammalian C1q acts as a lectin. Proc Natl Acad Sci U S A 2004;101:10127-31.
17. Pangburn MK, Ferreira VP, Cortes C. Discrimination between host and pathogens by the complement system. Vaccine 2008;26(Suppl. 8):I15-21.
18. Brouwer N, Dolman KM, van Zwieten R et al. Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop. Mol Immunol 2006;43:2051-60.
19. Harboe M, Ulvund G, Vien L, Fung M, Mollnes TE. The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin Exp Immunol 2004;138:439-46.
20. Dodds AW. Which came first, the lectin/classical pathway or the alternative pathway of complement? Immunobiology 2002;205:340-54.
21. Fujita T. Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol 2002;2:346-53.
22. Degn SE, Jensen L, Hansen AG et al. Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function. J Immunol 2012;189:3957-69.
23. Heja D, Kocsis A, Dobo J et al. Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2. Proc Natl Acad Sci U S A 2012;109:10498-503.
24. Moller-Kristensen M, Thiel S, Sjoholm A, Matsushita M, Jensenius JC. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway. Int Immunol 2007;19:141-9.
25. Heja D, Harmat V, Fodor K et al. Monospecific Inhibitors Show That Both Mannan-binding Lectin-associated Serine Protease-1 (MASP-1) and -2 Are Essential for Lectin Pathway Activation and Reveal Structural Plasticity of MASP-2. J Biol Chem 2012;287:20290-300.
26. Thiel S, Jensen L, Degn SE et al. Mannan-binding lectin (MBL)-associated serine protease-1 (MASP-1), a serine protease associated with humoral pattern-recognition molecules: normal and acute-phase levels in serum and stoichiometry of lectin pathway components. Clin Exp Immunol 2012;169:38-48.
27. Takahashi M, Ishida Y, Iwaki D et al. Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D. J Exp Med 2010;207:29-37.
28. Drickamer K. C-type lectin-like domains. Curr Opin Struct Biol 1999;9:585-90.
29. Drickamer K. Engineering galactose-binding activity into a C-type mannose-binding protein. Nature 1992;360:183-6.
30. Weis WI, Taylor ME, Drickamer K. The C-type lectin superfamily in the immune system. Immunol Rev 1998;163:19-34.
31. Keshi H, Sakamoto T, Kawai T et al. Identification and characterization of a novel human collectin CL-K1. Microbiol Immunol 2006;50:1001-13.
32. Jensen PH, Weilguny D, Matthiesen F, McGuire KA, Shi L, Hojrup P. Characterization of the oligomer structure of recombinant human mannan-binding lectin. J Biol Chem 2005;280:11043-51.
33. Wallis R, Drickamer K. Molecular determinants of oligomer formation and complement fixation in mannose-binding proteins. J Biol Chem 1999;274:3580-9.
34. Lipscombe RJ, Sumiya M, Summerfield JA, Turner MW. Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology 1995;85:660-7.
35. Teillet F, Lacroix M, Thiel S et al. Identification of the site of human mannan-binding lectin involved in the interaction with its partner serine proteases: the essential role of Lys55. J Immunol 2007;178:5710-6.
36. Girija UV, Dodds AW, Roscher S, Reid KB, Wallis R. Localization and characterization of the mannose-binding lectin (MBL)-associated-serine protease-2 binding site in rat ficolin-A: equivalent binding sites within the collagenous domains of MBLs and ficolins. J Immunol 2007;179:455-62.
37. Wallis R, Shaw JM, Uitdehaag J, Chen CB, Torgersen D, Drickamer K. Localization of the serine protease-binding sites in the collagen-like domain of mannose-binding protein: indirect effects of naturally occurring mutations on protease binding and activation. J Biol Chem 2004;279:14065-73.
38. Dong M, Xu S, Oliveira CL et al. Conformational changes in mannan-binding lectin bound to ligand surfaces. J Immunol 2007;178:3016-22.
39. Jensenius H, Klein DC, van Hecke M, Oosterkamp TH, Schmidt T, Jensenius JC. Mannan-binding lectin: structure, oligomerization, and flexibility studied by atomic force microscopy. J Mol Biol 2009;391:246-59.
40. Weis WI, Drickamer K, Hendrickson WA. Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 1992;360:127-34.
41. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods 2000;241:33-42.
42. Ohtani K, Suzuki Y, Eda S et al. Molecular cloning of a novel human collectin from liver (CL-L1). J Biol Chem 1999;274:13681-9.
43. Ohtani K, Suzuki Y, Eda S et al. The membrane-type collectin CL-P1 is a scavenger receptor on vascular endothelial cells. J Biol Chem 2001;276:44222-8.
44. Jang S, Ohtani K, Fukuoh A et al. Scavenger receptor collectin placenta 1 (CL-P1) predominantly mediates zymosan phagocytosis by human vascular endothelial cells. J Biol Chem 2009;284:3956-65.
45. Hansen S, Selman L, Palaniyar N et al. Collectin 11 (CL-11, CL-K1) is a MASP-1/3-associated plasma collectin with microbial-binding activity. J Immunol 2010;185:6096-104.
46. Wallis R. Interactions between mannose-binding lectin and MASPs during complement activation by the lectin pathway. Immunobiology 2007;212:289-99.
47. Ma YJ, Skjoedt MO, Garred P. Collectin-11/MASP complex formation triggers activation of the lectin complement pathway-the fifth lectin pathway initiation complex. J Innate Immun. 2012;5:242-50.
48. Ichijo H, Hellman U, Wernstedt C et al. Molecular cloning and characterization of ficolin, a multimeric protein with fibrinogen- and collagen-like domains. J Biol Chem 1993;268:14505-13.
49. Endo Y, Liu Y, Kanno K, Takahashi M, Matsushita M, Fujita T. Identification of the mouse H-ficolin gene as a pseudogene and orthology between mouse ficolins A/B and human L-/M-ficolins. Genomics 2004;84:737-44.
50. Le Y, Lee SH, Kon OL, Lu J. Human L-ficolin: plasma levels, sugar specificity, and assignment of its lectin activity to the fibrinogen-like (FBG) domain. FEBS Lett 1998;425:367-70.
51. Sugimoto R, Yae Y, Akaiwa M et al. Cloning and characterization of the Hakata antigen, a member of the ficolin/opsonin p35 lectin family. J Biol Chem 1998;273:20721-7.
52. Krarup A, Thiel S, Hansen A, Fujita T, Jensenius JC. L-ficolin is a pattern recognition molecule specific for acetyl groups. J Biol Chem 2004;279:47513-9.
53. Inaba S, Okochi K, Yae Y, Niklasson F, de Verder CH. Serological studies of an SLE-associated antigen-antibody system discovered as a precipitation reaction in agarose gel: the HAKATA antigen-antibody system. Fukuoka Igaku Zasshi 1990;81:284-91.
54. Yae Y, Inaba S, Sato H, Okochi K, Tokunaga F, Iwanaga S. Isolation and characterization of a thermolabile beta-2 macroglycoprotein ('thermolabile substance' or 'Hakata antigen') detected by precipitating (auto) antibody in sera of patients with systemic lupus erythematosus. Biochim Biophys Acta 1991;1078:369-76.
55. Edgar PF. Hucolin, a new corticosteroid-binding protein from human plasma with structural similarities to ficolins, transforming growth factor-beta 1-binding proteins. FEBS Lett 1995;375:159-61.
56. Harumiya S, Omori A, Sugiura T, Fukumoto Y, Tachikawa H, Fujimoto D. EBP-37, a new elastin-binding protein in human plasma: structural similarity to ficolins, transforming growth factor-beta 1-binding proteins. J Biochem 1995;117:1029-35.
57. Matsushita M, Endo Y, Taira S et al. A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin. J Biol Chem 1996;271:2448-54.
58. Endo Y, Sato Y, Matsushita M, Fujita T. Cloning and characterization of the human lectin P35 gene and its related gene. Genomics 1996;36:515-21.
59. Lu J, Tay PN, Kon OL, Reid KB. Human ficolin: cDNA cloning, demonstration of peripheral blood leucocytes as the major site of synthesis and assignment of the gene to chromosome 9. Biochem J 1996;313(Pt 2):473-8.
60. Akaiwa M, Yae Y, Sugimoto R et al. Hakata antigen, a new member of the ficolin/opsonin p35 family, is a novel human lectin secreted into bronchus/alveolus and bile. J Histochem Cytochem 1999;47:777-86.
61. Krarup A, Sorensen UB, Matsushita M, Jensenius JC, Thiel S. Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun 2005;73:1052-60.
62. Tsujimura M, Ishida C, Sagara Y et al. Detection of serum thermolabile beta-2 macroglycoprotein (Hakata antigen) by enzyme-linked immunosorbent assay using polysaccharide produced by Aerococcus viridans. Clin Diagn Lab Immunol 2001;8:454-9.
63. Tsujimura M, Miyazaki T, Kojima E et al. Serum concentration of Hakata antigen, a member of the ficolins, is linked with inhibition of Aerococcus viridans growth. Clin Chim Acta 2002;325:139-46.
64. Matsushita M, Kuraya M, Hamasaki N, Tsujimura M, Shiraki H, Fujita T. Activation of the lectin complement pathway by H-ficolin (Hakata antigen). J Immunol 2002;168:3502-6.
65. Cseh S, Vera L, Matsushita M, Fujita T, Arlaud GJ, Thielens NM. Characterization of the interaction between L-ficolin/p35 and mannan-binding lectin-associated serine proteases-1 and -2. J Immunol 2002;169:5735-43.
66. Matsushita M, Endo Y, Fujita T. Cutting edge: complement-activating complex of ficolin and mannose-binding lectin-associated serine protease. J Immunol 2000;164:2281-4.
67. Frederiksen PD, Thiel S, Larsen CB, Jensenius JC. M-ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement. Scand J Immunol 2005;62:462-73.
68. Teh C, Le Y, Lee SH, Lu J. M-ficolin is expressed on monocytes and is a lectin binding to N-acetyl-D-glucosamine and mediates monocyte adhesion and phagocytosis of Escherichia coli. Immunology 2000;101:225-32.
69. Liu Y, Endo Y, Iwaki D et al. Human M-ficolin is a secretory protein that activates the lectin complement pathway. J Immunol 2005;175:3150-6.
70. Lu J, Le Y, Kon OL, Chan J, Lee SH. Biosynthesis of human ficolin, an Escherichia coli-binding protein, by monocytes: comparison with the synthesis of two macrophage-specific proteins, C1q and the mannose receptor. Immunology 1996;89:289-94.
71. Wittenborn T, Thiel S, Jensen L, Nielsen HJ, Jensenius JC. Characteristics and Biological Variations of M-Ficolin, a Pattern Recognition Molecule, in Plasma. J Innate Immun 2010;2:167-80.
72. Honoré C, Rørvig S, Hummelshøj T, Skjoedt M-O, Borregaard N, Garred P. Tethering of Ficolin-1 to cell surfaces through recognition of sialic acid by the fibrinogen-like domain. J Leukoc Biol 2010;88:145-58.
73. Gout E, Garlatti V, Smith DF et al. Carbohydrate recognition properties of human ficolins: glycan array screening reveals the sialic acid binding specificity of M-ficolin. J Biol Chem 2010;285:6612-22.
74. Baumgarth N, Tung JW, Herzenberg LA. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immunopathol 2005;26:347-62.
75. Brodsky-Doyle B, Leonard KR, Reid KB. Circular-dichroism and electron-microscopy studies of human subcomponent C1q before and after limited proteolysis by pepsin. Biochem J 1976;159:279-86.
76. Schumaker VN, Poon PH, Seegan GW, Smith CA. Semi-flexible joint in the C1q subunit of the first component of human complement. J Mol Biol 1981;148:191-7.
77. Voss T, Eistetter H, Schafer KP, Engel J. Macromolecular organization of natural and recombinant lung surfactant protein SP 28-36. Structural homology with the complement factor C1q. J Mol Biol 1988;201:219-27.
78. Ohashi T, Erickson HP. Two oligomeric forms of plasma ficolin have differential lectin activity. J Biol Chem 1997;272:14220-6.
79. Degn SE, Hansen AG, Steffensen R, Jacobsen C, Jensenius JC, Thiel S. MAp44, a human protein associated with pattern recognition molecules of the complement system and regulating the lectin pathway of complement activation. J Immunol 2009;183:7371-8.
80. Gregory LA, Thielens NM, Arlaud GJ, Fontecilla-Camps JC, Gaboriaud C. X-ray structure of the Ca2+-binding interaction domain of C1s. Insights into the assembly of the C1 complex of complement. J Biol Chem 2003;278:32157-64.
81. Gregory LA, Thielens NM, Matsushita M et al. The X-ray structure of human mannan-binding lectin-associated protein 19 (MAp19) and its interaction site with mannan-binding lectin and L-ficolin. J Biol Chem 2004;279:29391-7.
82. Thielens NM, Cseh S, Thiel S et al. Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and -2, MBL-associated protein 19, and MBL. J Immunol 2001;166:5068-77.
83. Wallis R, Dodd RB. Interaction of mannose-binding protein with associated serine proteases: effects of naturally occurring mutations. J Biol Chem 2000;275:30962-9.
84. Chen CB, Wallis R. Stoichiometry of complexes between mannose-binding protein and its associated serine proteases. Defining functional units for complement activation. J Biol Chem 2001;276:25894-902.
85. Degn SE, Jensen L, Olszowski T, Jensenius JC, Thiel S. Co-complexes of MASP-1 and MASP-2 associated with the soluble pattern recognition molecules drive lectin pathway activation in a manner inhibitable by MAp44. J Immunol (in press).
86. Harmat V, Gal P, Kardos J et al. The structure of MBL-associated serine protease-2 reveals that identical substrate specificities of C1s and MASP-2 are realized through different sets of enzyme-substrate interactions. J Mol Biol 2004;342:1533-46.
87. Rossi V, Teillet F, Thielens NM, Bally I, Arlaud GJ. Functional characterization of complement proteases C1s/mannan-binding lectin-associated serine protease-2 (MASP-2) chimeras reveals the higher C4 recognition efficacy of the MASP-2 complement control protein modules. J Biol Chem 2005;280:41811-8.
88. Teillet F, Gaboriaud C, Lacroix M, Martin L, Arlaud GJ, Thielens NM. Crystal structure of the CUB1-EGF-CUB2 domain of human MASP-1/3 and identification of its interaction sites with mannan-binding lectin and ficolins. J Biol Chem 2008;283:25715-24.
89. Teillet F, Dublet B, Andrieu JP, Gaboriaud C, Arlaud GJ, Thielens NM. The two major oligomeric forms of human mannan-binding lectin: chemical characterization, carbohydrate-binding properties, and interaction with MBL-associated serine proteases. J Immunol 2005;174:2870-7.
90. Gingras AR, Girija UV, Keeble AH et al. Structural basis of mannan-binding lectin recognition by its associated serine protease MASP-1: implications for complement activation. Structure 2011;19:1635-43.
91. Gal P, Harmat V, Kocsis A et al. A true autoactivating enzyme. Structural insight into mannose-binding lectin-associated serine protease-2 activations. J Biol Chem 2005;280:33435-44.
92. Degn SE, Thiel S, Jensenius JC. Recombinant expression of the autocatalytic complement protease MASP-1 is crucially dependent on co-expression with its inhibitor, C1 inhibitor. Protein Expr Purif 2013;88:173-82.
93. Dobó J, Harmat V, Beinrohr L, Sebestyén E, Závodszky P, Gál P. MASP-1, a promiscuous complement protease: structure of its catalytic region reveals the basis of its broad specificity. J Immunol 2009;183:1207-14.
94. Skjoedt MO, Roversi P, Hummelshoj T et al. Crystal structure and functional characterization of the complement regulator mannose-binding lectin (MBL)/ficolin-associated protein-1 (MAP-1). J Biol Chem 2012;287:32913-21.
95. Traub W, Piez KA. The chemistry and structure of collagen. Adv Protein Chem 1971;25:243-352.
96. Kramer RZ, Bella J, Mayville P, Brodsky B, Berman HM. Sequence dependent conformational variations of collagen triple-helical structure. Nat Struct Biol 1999;6:454-7.
97. Sheriff S, Chang CY, Ezekowitz RA. Human mannose-binding protein carbohydrate recognition domain trimerizes through a triple alpha-helical coiled-coil. Nat Struct Biol 1994;1:789-94.
98. Tanio M, Kondo S, Sugio S, Kohno T. Trivalent recognition unit of innate immunity system: crystal structure of trimeric human M-ficolin fibrinogen-like domain. J Biol Chem 2007;282:3889-95.
99. Garlatti V, Belloy N, Martin L et al. Structural insights into the innate immune recognition specificities of L- and H-ficolins. EMBO J 2007;26:623-33.
100. Crouch E, Persson A, Chang D, Heuser J. Molecular structure of pulmonary surfactant protein D (SP-D). J Biol Chem 1994;269:17311-9.
101. Feinstein A, Munn EA, Richardson NE. The three-dimensional conformation of M and A globulin molecules. Ann N Y Acad Sci 1971;190:104-21.
102. Poon PH, Phillips ML, Schumaker VN. Immunoglobulin M possesses two binding sites for complement subcomponent C1q, and soluble 1:1 and 2:1 complexes are formed in solution at reduced ionic strength. J Biol Chem 1985;260:9357-65.